|
Volumn 12, Issue 2, 2009, Pages 191-192
|
FDAMA 1997 section 114: Another look
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HAEMOPHILUS INFLUENZAE TYPE B VACCINE;
INSULIN;
PRESCRIPTION DRUG;
ACT;
DRUG LABELING;
EDITORIAL;
FDA MODERNIZATION ACT;
FOOD AND DRUG ADMINISTRATION;
FRACTURE;
GLUCOSE BLOOD LEVEL;
HEALTH CARE COST;
HEALTH CARE POLICY;
HEALTH CARE SYSTEM;
HEALTH SERVICE;
HEART FAILURE;
HUMAN;
INSULIN DEPENDENT DIABETES MELLITUS;
KIDNEY DISEASE;
MEDICAL EDUCATION;
MENINGITIS;
MORBIDITY;
MORTALITY;
OSTEOSCLEROSIS;
PRIORITY JOURNAL;
RETINOPATHY;
RHEUMATOID ARTHRITIS;
DRUG APPROVAL;
DRUG INDUSTRY;
LEGISLATION AND JURISPRUDENCE;
PHARMACOECONOMICS;
QUALITY ADJUSTED LIFE YEAR;
UNITED STATES;
DRUG APPROVAL;
DRUG INDUSTRY;
DRUG LABELING;
ECONOMICS, PHARMACEUTICAL;
HUMANS;
PRESCRIPTION DRUGS;
QUALITY-ADJUSTED LIFE YEARS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 60349088130
PISSN: 10983015
EISSN: 15244733
Source Type: Journal
DOI: 10.1111/j.1524-4733.2008.00432.x Document Type: Editorial |
Times cited : (5)
|
References (2)
|